BCD BIOSCIENCE
BCD Bioscience is an emerging biotechnology spinout from UC Davis that creates ingredients for food and biopharmaceutical applications. The company was founded in 2019 and is headquartered in Davis, California, United States.
BCD BIOSCIENCE
Social Links:
Industry:
Biotechnology Food And Beverage Health Care
Founded:
2019-01-01
Address:
Davis, California, United States
Country:
United States
Website Url:
http://www.bcdbio.com
Total Employee:
11+
Status:
Active
Contact:
(530) 400-8155
Email Addresses:
[email protected]
Total Funding:
16.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Euro Google Apps For Business Typekit
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Gelesis
Gelesis is a biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
iSELECT FUND
iSELECT FUND investment in Series A - BCD Bioscience
Seventure Partners
Seventure Partners investment in Series A - BCD Bioscience
Skyviews Life Science
Skyviews Life Science investment in Series A - BCD Bioscience
Acre Venture Partners
Acre Venture Partners investment in Series A - BCD Bioscience
Collaborative Fund
Collaborative Fund investment in Series A - BCD Bioscience
Skyviews Life Science
Skyviews Life Science investment in Series A - BCD Bioscience
iSELECT FUND
iSELECT FUND investment in Series A - BCD Bioscience
Collaborative Fund
Collaborative Fund investment in Series A - BCD Bioscience
Seventure Partners
Seventure Partners investment in Series A - BCD Bioscience
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - BCD Bioscience
Official Site Inspections
http://www.bcdbio.com Semrush global rank: 9.71 M Semrush visits lastest month: 114
- Host name: f2.68.7e4b.ip4.static.sl-reverse.com
- IP address: 75.126.104.242
- Location: Dallas United States
- Latitude: 32.9379
- Longitude: -96.8384
- Metro Code: 623
- Timezone: America/Chicago
- Postal: 75244

More informations about "BCD Bioscience"
BCN Biosciences - Home
What We Do BCN Biosciences employs its leading talent for the development and commercialization of both small molecule and biological therapeutic drug candidates. BCN possesses an experienced team of drug discovery and โฆSee details»
BCN Biosciences - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +1 424 209 2230 BCN Biosciences is developing novel drugs in oncology as well as for the protection of normal tissues from โฆSee details»
Bcn Biosciences - Overview, News & Similar companies - ZoomInfo
Bcn Biosciences contact info: Phone number: (424) 209-2230 Website: www.bcnbio.com What does Bcn Biosciences do? BCN Biosciences is a preclinical biotechnology corporation with โฆSee details»
Bcn Biosciences Company Profile | Management and Employees โฆ
[email protected]: Bcn Biosciences Top Competitors. Company Employees Revenue Top technologies; Revitope Oncology Inc. 12: $2.3 M: Cellectar Biosciences Inc. 15: $3.8 M: โฆSee details»
BCN Biosciences - PitchBook
Www.bcnbio.com. Ownership Status. Privately Held (backing) Financing Status. Accelerator/Incubator Backed. Corporate Office. 200 West 64th Street; Inglewood, CA 90302 โฆSee details»
Team - BCN Biosciences
Dr. Roger Ulrich has thirty years of experience in pharmaceutical R&D in both large and small company settings. He was Founder and Chief Development Officer at Calistoga โฆSee details»
BCN BIOSCIENCES, LLC - VentureRadar
"BCN Biosciences is a preclinical biotechnology corporation with core competency in the oncology drug discovery and development market. BCN057, is a novel small molecule drug being โฆSee details»
BCN Biosciences - About Us
Please email us at [email protected] for any collaborative or business development requests. RESEARCH An ongoing research program at BCN is the investigation of new endothelial โฆSee details»
BCN Biosciences - Craft
BCN Biosciences is a preclinical biotechnology company that focuses on the oncology drug discovery and development market. It develops and commercializes both small molecule and โฆSee details»
BCD Bioscience's Board of Directors - The Org
About. The board of directors at BCD Bioscience have a wealth of experience in finance and strategy. Co-founder and managing partner Acre Venture Partners, chief financial officer โฆSee details»
BCD Bioscience - VentureRadar
"BCD Bioscience is creating the worldโs first broad library of oligosaccharides with diverse natural structures, and linking these structures to their functions as prebiotics and immunomodulators.See details»
BCD Bioscience's Leadership Team - Team members and org chart โฆ
The leadership team at BCD Bioscience has a history of experience in the clinical, research, and business aspects of the food and agriculture industries.See details»
Bcd Bioscience - Overview, News & Similar companies - ZoomInfo
Apr 14, 2022 Who is Bcd Bioscience. BCD Bioscience was founded in 2019 as a spin-out from UC Davis, to exploit the functional and health benefits of oligosaccharides obtained from nat โฆSee details»
BCN Biosciences - Collaborations
This collaboration has resulted in a series of highly novel small molecule leads obtained by screening proprietary libraries with multiple phenotypic endpoints such as cellular clonogenic โฆSee details»
BCD Bioscience - Biotech Careers
BCD Bioscience is creating the world's first broad library of oligosaccharides with diverse natural structures, and linking these structures to their functions as prebiotics and immunomodulators. โฆSee details»
BCD Bioscience Receives Research Grant to Create Functional ...
Oct 29, 2019 BCD Bioscience (http://www.bcdbio.com; โBCDโ), a carbohydrate-mediated solution provider, announces that it has been awarded a grant by the Bill &See details»
BCD Bioscience, a Precision Prebiotic Fiber Company, Raises $12M โฆ
Apr 14, 2022 DAVIS, Calif.--(BUSINESS WIRE)--BCD Bioscience, a biotechnology company creating precision prebiotics from natural fibers, today announced that it has completed an โฆSee details»
BCN Biosciences - Products
BCN Bioscience has its core focus on the development of novel monoclonal antibodies against endothelial derived drug targets.. BCN has explored multiple mAB against endothelial derived โฆSee details»
Pioneering scientists create designer prebiotics to disrupt the ...
Jan 13, 2020 After winning one of the top three spots in NutraIngredientsโ Probiota Pioneers competition, the co-founders behind BCD Bioscience, in California, will present their startup โฆSee details»
BCD Bioscience, a Precision Prebiotic Fiber Company, Raises $12M โฆ
DAVIS, Calif., April 14, 2022-- BCD Bioscience, a biotechnology company creating precision prebiotics from natural fibers, today announced that it has completed an oversubscribed โฆSee details»